The Infection Control Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Infection Control Market:
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
According to The Business Research Company’s Infection Control Global Market Report 2024, The infection control market size has grown strongly in recent years. It will grow from $119.1 billion in 2023 to $126.25 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to healthcare-associated infections (hais), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure.
The infection control market size is expected to see strong growth in the next few years. It will grow to $164.6 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to pandemic preparedness, growing healthcare infrastructure, rising antimicrobial resistance, evolving regulatory landscape, public health initiatives. Major trends in the forecast period include technological integration in healthcare, technological innovations in infection control products, technological advancements in disinfection, increased emphasis on hand hygiene, rapid sterilization techniques.
The increasing incidence of hospital-acquired infections is expected to propel the growth of the infection control market. Healthcare-associated infections, also known as hospital-acquired infections, refer to one that is contracted while a patient is there or in another healthcare facility. These infections include bloodstream infections linked to central-line catheter-associated urinary tract infections. Infection control prevents hospital-acquired infections from one-to-one transmission of communicable diseases through high-level services, hygiene and sterilization services, so the ease factor boosts the infection control market. For instance, in May 2022, according to the reports by the World Health Organization, a Switzerland-based health agency, more than 24% of patients worldwide were affected by healthcare-associated infections in 2022. Furthermore, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, in the US, there were estimates that hospital-acquired infections accounted for an estimated 1.7 million infections and 99,000 associated deaths each year, and additionally, 32% of all healthcare-acquired infections in the US by 2022. These numbers are expected to rise in the future. Therefore, the increasing incidence of hospital-acquired infections drives the infection control market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10061&type=smp
The infection control market covered in this report is segmented –
1) By Type:Disinfectors, Sterilization, Equipment, Consumables And Accessories, Services
2) By Distribution Channel: Direct Tender, Retail Sales, Third Party Distributors
3) By Application: Surgical Instruments, Endoscopes, Ultrasound Probes, Other Applications
4) By End User: Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other End Users
Major companies operating in the infection control market are developing advanced technologies such as digital infection prevention systems to meet larger customer bases, more sales, and increase revenue. A digital infection prevention system refers to a technologically driven solution designed to monitor, analyze, and manage infection prevention measures within various settings, such as healthcare facilities. For instance, in June 2021, Nanosonics, an Australia-based infection prevention company, launched AuditPro. AuditPro stands out as a specialized tool tailored for infection preventionists and quality managers, aiming to enhance and standardize compliance with infection control measures. Its unique feature lies in its ability to effectively manage healthcare-associated infection risks associated with a diverse array of medical instruments.
The infection control market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
